1.
Clin Case Rep
; 10(4): e05592, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35414910
RESUMO
Tolvaptan is a key drug for patients with heart failure. Here, we present a 92-year-old woman, whose PT-INR/dose increased from 1.74 to 3.30 after warfarin and tolvaptan co-administration, and resulted in a large cerebral infarction after warfarin dose down. Therefore, the interaction between these two drugs may be clinically significant.